Paper3673709
Salvage pathways as targets of chemotherapy.
Weber G and 5 others. Adv Enzyme Regul, 1987. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Salvage pathways as targets of chemotherapy. Papers, record 3673709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3673709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Enzyme Inhibitors | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Purines | Major topic |
| Pyrimidines | Major topic |
| Amphotericin B | |
| Animals | |
| Cell Survival | |
| Dipyridamole | |
| Liver | |
| Nucleosides | |
| Nucleotides | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-13526 | NCI NIH HHS | United States | P01CA013526 | PubMed and NIH | NIH RePORTER |
| CA-42510 | NCI NIH HHS | United States | R35CA042510 | PubMed and NIH | NIH RePORTER |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32554188 | Microbiota-Sourced Purines Support Wound Healing and Mucous Barrier Function. | iScience | 2020 | https://conductscience.org/library/papers/32554188 | PubMed |
| 30233375 | Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30233375 | PubMed |
| 29570682 | Resistance to 6-Methylpurine is Conferred by Defective Adenine Phosphoribosyltransferase in Tetrahymena. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/29570682 | PubMed |
| 17881236 | Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors. | Bioorg Med Chem | 2007 | https://conductscience.org/library/papers/17881236 | PubMed |
| 7767952 | Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7767952 | PubMed |
| 2736709 | Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2736709 | PubMed |
| 1726536 | A study of deoxyribonucleotide metabolism and its relation to DNA synthesis. Supercomputer simulation and model-system analysis. | Cell Biophys | 1991 | https://conductscience.org/library/papers/1726536 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3673709
GET https://conductscience.org/api/papers/v1/3673709/authors